Yasmeen Rahimi
Stock Analyst at Piper Sandler
(4.27)
# 671
Out of 4,496 analysts
68
Total ratings
50.82%
Success rate
17%
Average return
Main Sectors:
Top Industries:
40 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMUX Immunic | Reiterates: Overweight | $28 | $1.41 | +1,885.82% | 3 | Jul 16, 2024 | |
| CRNX Crinetics Pharmaceuticals | Maintains: Overweight | $97 | $52.66 | +84.20% | 4 | Jul 2, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $270 | $54.96 | +391.27% | 3 | Jul 1, 2024 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $48 | $21.36 | +124.72% | 2 | Jul 1, 2024 | |
| TECX Tectonic Therapeutic | Initiates: Overweight | $76 | $16.50 | +360.61% | 1 | Jun 26, 2024 | |
| ALT Altimmune | Maintains: Overweight | $25 | $6.28 | +298.09% | 3 | Jun 21, 2024 | |
| BNTC Benitec Biopharma | Initiates: Overweight | $30 | $9.22 | +225.38% | 1 | Jun 13, 2024 | |
| DSGN Design Therapeutics | Upgrades: Overweight | $6 → $12 | $4.07 | +194.84% | 2 | May 7, 2024 | |
| ZURA Zura Bio | Initiates: Overweight | $26 | $3.49 | +644.99% | 1 | May 3, 2024 | |
| VRNA Verona Pharma | Maintains: Overweight | $31 → $36 | $22.95 | +56.86% | 2 | Apr 16, 2024 | |
| UNCY Unicycive Therapeutics | Initiates: Overweight | $9 | $0.40 | +2,150.00% | 1 | Apr 4, 2024 | |
| KRRO Korro Bio | Maintains: Overweight | $180 | $45.57 | +295.00% | 2 | Mar 27, 2024 | |
| GOSS Gossamer Bio | Maintains: Overweight | $15 | $1.03 | +1,356.31% | 1 | Mar 27, 2024 | |
| MDGL Madrigal Pharmaceuticals | Reiterates: Overweight | $336 | $287.24 | +16.98% | 3 | Mar 14, 2024 | |
| SVRA Savara | Maintains: Overweight | $7 → $16 | $4.47 | +257.94% | 2 | Mar 4, 2024 | |
| ANAB AnaptysBio | Initiates: Overweight | $80 | $33.70 | +137.39% | 1 | Feb 16, 2024 | |
| SLNO Soleno Therapeutics | Initiates: Overweight | $93 | $46.96 | +98.04% | 1 | Feb 5, 2024 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Overweight | $37 | $18.90 | +95.77% | 1 | Jan 16, 2024 | |
| GPCR Structure Therapeutics | Maintains: Overweight | $58 → $93 | $37.44 | +148.40% | 3 | Oct 27, 2023 | |
| TRML Tourmaline Bio | Initiates: Overweight | $65 | $14.71 | +341.88% | 1 | Oct 25, 2023 | |
| IMVT Immunovant | Maintains: Overweight | $28 → $57 | $27.97 | +103.79% | 2 | Oct 24, 2023 | |
| SGMT Sagimet Biosciences | Initiates: Overweight | $67 | $3.09 | +2,068.28% | 1 | Aug 8, 2023 | |
| PTGX Protagonist Therapeutics | Reiterates: Overweight | $35 | $35.55 | -1.55% | 3 | Jul 3, 2023 | |
| SLRN Acelyrin | Initiates: Overweight | $68 | $6.51 | +944.55% | 1 | May 30, 2023 | |
| ALLK Allakos | Initiates: Overweight | $22 | $0.69 | +3,092.11% | 1 | Mar 7, 2023 | |
| ENTA Enanta Pharmaceuticals | Maintains: Overweight | $87 | $14.32 | +507.54% | 3 | Feb 8, 2023 | |
| PRTA Prothena Corporation | Initiates: Overweight | $94 | $23.58 | +298.64% | 1 | Jan 27, 2023 | |
| ALGS Aligos Therapeutics | Maintains: Overweight | $3 → $7 | $0.50 | +1,289.72% | 4 | Jan 17, 2023 | |
| LXRX Lexicon Pharmaceuticals | Initiates: Overweight | $10 | $1.99 | +402.51% | 1 | Aug 12, 2022 | |
| CYTK Cytokinetics | Maintains: Overweight | $50 → $72 | $56.41 | +27.64% | 1 | Jun 10, 2022 | |
| RPHM Reneo Pharmaceuticals | Maintains: Overweight | $45 → $18 | $1.48 | +1,116.22% | 2 | May 18, 2022 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $63 → $27 | $12.36 | +118.45% | 1 | May 18, 2022 | |
| ETNB 89bio | Maintains: Overweight | $54 → $19 | $8.35 | +127.54% | 2 | May 18, 2022 | |
| VTYX Ventyx Biosciences | Initiates: Overweight | n/a | $2.55 | - | 1 | Nov 15, 2021 | |
| TNYA Tenaya Therapeutics | Initiates: Overweight | n/a | $3.39 | - | 1 | Aug 24, 2021 | |
| VXRT Vaxart | Initiates: Overweight | n/a | $0.68 | - | 1 | Jun 11, 2021 | |
| AMRN Amarin Corporation | Initiates: Overweight | n/a | $0.78 | - | 1 | Aug 26, 2020 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Overweight | n/a | $23.79 | - | 1 | Aug 26, 2020 | |
| LUMO Lumos Pharma | Initiates: Overweight | n/a | $1.46 | - | 1 | Aug 26, 2020 | |
| MIRM Mirum Pharmaceuticals | Initiates: Overweight | n/a | $39.49 | - | 1 | Jul 31, 2020 |
Immunic
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.41
Upside: +1,885.82%
Crinetics Pharmaceuticals
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $52.66
Upside: +84.20%
Praxis Precision Medicines
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $54.96
Upside: +391.27%
Edgewise Therapeutics
Jul 1, 2024
Maintains: Overweight
Price Target: $48
Current: $21.36
Upside: +124.72%
Tectonic Therapeutic
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $16.50
Upside: +360.61%
Altimmune
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $6.28
Upside: +298.09%
Benitec Biopharma
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $9.22
Upside: +225.38%
Design Therapeutics
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $4.07
Upside: +194.84%
Zura Bio
May 3, 2024
Initiates: Overweight
Price Target: $26
Current: $3.49
Upside: +644.99%
Verona Pharma
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $22.95
Upside: +56.86%
Unicycive Therapeutics
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.40
Upside: +2,150.00%
Korro Bio
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $45.57
Upside: +295.00%
Gossamer Bio
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $1.03
Upside: +1,356.31%
Madrigal Pharmaceuticals
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $287.24
Upside: +16.98%
Savara
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $4.47
Upside: +257.94%
AnaptysBio
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $33.70
Upside: +137.39%
Soleno Therapeutics
Feb 5, 2024
Initiates: Overweight
Price Target: $93
Current: $46.96
Upside: +98.04%
NewAmsterdam Pharma Company
Jan 16, 2024
Initiates: Overweight
Price Target: $37
Current: $18.90
Upside: +95.77%
Structure Therapeutics
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $37.44
Upside: +148.40%
Tourmaline Bio
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $14.71
Upside: +341.88%
Immunovant
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $27.97
Upside: +103.79%
Sagimet Biosciences
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $3.09
Upside: +2,068.28%
Protagonist Therapeutics
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $35.55
Upside: -1.55%
Acelyrin
May 30, 2023
Initiates: Overweight
Price Target: $68
Current: $6.51
Upside: +944.55%
Allakos
Mar 7, 2023
Initiates: Overweight
Price Target: $22
Current: $0.69
Upside: +3,092.11%
Enanta Pharmaceuticals
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $14.32
Upside: +507.54%
Prothena Corporation
Jan 27, 2023
Initiates: Overweight
Price Target: $94
Current: $23.58
Upside: +298.64%
Aligos Therapeutics
Jan 17, 2023
Maintains: Overweight
Price Target: $3 → $7
Current: $0.50
Upside: +1,289.72%
Lexicon Pharmaceuticals
Aug 12, 2022
Initiates: Overweight
Price Target: $10
Current: $1.99
Upside: +402.51%
Cytokinetics
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $56.41
Upside: +27.64%
Reneo Pharmaceuticals
May 18, 2022
Maintains: Overweight
Price Target: $45 → $18
Current: $1.48
Upside: +1,116.22%
Pliant Therapeutics
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $12.36
Upside: +118.45%
89bio
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $8.35
Upside: +127.54%
Ventyx Biosciences
Nov 15, 2021
Initiates: Overweight
Price Target: n/a
Current: $2.55
Upside: -
Tenaya Therapeutics
Aug 24, 2021
Initiates: Overweight
Price Target: n/a
Current: $3.39
Upside: -
Vaxart
Jun 11, 2021
Initiates: Overweight
Price Target: n/a
Current: $0.68
Upside: -
Amarin Corporation
Aug 26, 2020
Initiates: Overweight
Price Target: n/a
Current: $0.78
Upside: -
Arcturus Therapeutics Holdings
Aug 26, 2020
Initiates: Overweight
Price Target: n/a
Current: $23.79
Upside: -
Lumos Pharma
Aug 26, 2020
Initiates: Overweight
Price Target: n/a
Current: $1.46
Upside: -
Mirum Pharmaceuticals
Jul 31, 2020
Initiates: Overweight
Price Target: n/a
Current: $39.49
Upside: -